NYSE$SEM

Select Medical Holdings Corporation · Q2 2020 earnings

Q2 2020 earnings · · Investor relations

Briefing

Announced results for the second quarter, with revenue decrease partially offset by Provider Relief Fund payments.

Select Medical reported net operating revenues of $1,232.7 million for the second quarter ended June 30, 2020, compared to $1,361.4 million for the same quarter, prior year. Net income increased 12.5% to $67.5 million, and earnings per common share was $0.39 on a fully diluted basis.

  • Net operating revenues were $1,232.7 million, compared to $1,361.4 million for the same quarter, prior year.
  • Income from operations was $119.5 million, including $55.0 million from the Provider Relief Fund.
  • Net income increased 12.5% to $67.5 million compared to the same quarter, prior year.
  • Earnings per common share was $0.39 on a fully diluted basis, compared to $0.33 for the same quarter, prior year.

Headline financials

Total Revenue

$1.23B

Previous: $1.36B-9.4%
EPS (adj)

$0.38

Previous: $0.33+15.2%
Free Cash Flow

$51.7M

Previous: $44.8M+15.2%
Net Income

$51.7M

Previous: $44.8M+15.2%
Operating Income

$120M

Previous: $125M-4.3%
Gross Profit

-$1.08B

Previous: $2.44M-44426.6%
Cash & Equivalents

$510M

Previous: $124M+311.0%
Total Assets

$7.47B

Previous: $7.11B+5.1%
Stock-Based Comp

$6.96M

Previous: $6.36M+9.5%

Revenue & EPS history

Select Medical · Revenue · Quarterly

$1.23B

Q2 2020-9.4%vs Q2 2019
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

Select Medical · $855M total across 3 segments · Q2 2020

  • Critical Illness Recovery
    $520M+12.7%
  • Rehabilitation Hospital
    $169M+5.2%
  • Outpatient Rehabilitation
    $167M-36.2%

Forward guidance

Select Medical will host a conference call regarding its second quarter results, as well as its business outlook and the impact of the COVID-19 pandemic on each of its reportable segments, on Friday, July 31, 2020, at 9:00am ET.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q2 2020

Historical avgQ2 2020

-0.3%

Avg return

Earnings day

+0.1%

Avg return

5 days after

+0.5%

Avg return

30 days after

49%

32 / 65 earnings

Positive

+18.8%

Q3 2018

Best reaction

-22.2%

Q1 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.2%+0.1%+0.7%
Q4 2025-6.5%-7.3%+1.1%
Q3 2025-5.8%-5.1%+9.1%
Q1 2025-22.2%-17.7%-16.2%
Q4 2024-7.2%-2.9%-13.1%
Q3 2024+9.4%+13.3%+19.3%
Q2 2024-14.0%-17.2%-9.3%
Q1 2024+12.3%+17.0%+23.5%
Q4 2023+6.7%+4.6%+7.7%
Q3 2023-1.2%-2.7%+3.9%
Q2 2023-1.3%-2.5%-4.3%
Q1 2023+4.8%-0.8%-2.8%
Q4 2022-7.8%-9.1%-17.6%
Q3 2022-6.5%-10.9%+0.9%
Q2 2022-4.1%-11.1%-14.7%
Q1 2022+0.9%-4.2%+10.6%
Q4 2021+1.1%+2.2%+3.5%
Q3 2021+2.4%-0.9%-18.4%
Q2 2021-3.3%-6.9%-7.7%
Q1 2021-2.5%-3.1%+4.9%
Q4 2020+10.5%+16.9%+20.5%
Q3 2020-1.7%+8.5%+15.4%
Q2 2020+13.1%+14.7%+21.2%
Q1 2020-15.3%-12.9%-6.3%
Q4 2019+8.9%-0.1%-55.6%
Q3 2019+5.7%+10.6%+22.9%
Q2 2019-5.8%-5.8%-3.1%
Q1 2019+1.7%+3.0%-1.3%
Q4 2018+0.1%-4.8%-10.1%
Q3 2018+18.8%+21.2%+16.9%
Q2 2018-5.0%-7.5%-6.6%
Q1 2018-4.4%-3.5%-2.9%
Q4 2017+11.2%+11.4%+7.8%
Q3 2017-7.8%-9.4%-6.5%
Q2 2017+8.6%+12.7%+18.7%
Q1 2017+5.9%+1.1%+3.7%
Q4 2016+9.6%+11.6%-3.1%
Q3 2016-8.2%-6.1%-1.2%
Q2 2016+10.6%+6.3%+9.3%
Q1 2016-4.5%
Q4 2015+10.9%
Q3 2015+5.0%
Q2 2015+0.1%
Q1 2015+0.0%
Q4 2014-5.2%
Q3 2014+11.3%
Q2 2014-12.4%
Q1 2014+0.5%
Q4 2013+1.7%
Q3 2013+1.1%
Q2 2013+1.3%
Q1 2013-2.5%
Q4 2012+4.0%
Q3 2012+10.0%
Q2 2012+9.1%
Q1 2011-3.2%
Q1 2012+1.1%
Q4 2009-0.4%
Q4 2011-0.4%
Q3 2010-2.4%
Q3 2011-2.4%
Q4 2010-15.8%
Q2 2010-15.8%
Q2 2011-15.8%
Q1 2010-7.2%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro